(Q39042892)

8 September 2017

title

Coartem(®): a decade of patient-centric malaria management (English)

1 reference

8 September 2017

0 references

1

1 reference

8 September 2017

Heiner Grueninger

2

1 reference

8 September 2017

publication date

3 May 2012

1 reference

Expert Review of Anti-infective Therapy

8 September 2017

published in

1 reference

8 September 2017

volume

10

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

645-659

1 reference

Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment

8 September 2017

cites work

1 reference

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar

21 January 2018

1 reference

Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial

21 January 2018

1 reference

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children

21 January 2018

1 reference

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine

21 January 2018

1 reference

Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

21 January 2018

1 reference

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.

21 January 2018

1 reference

Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers

21 January 2018

1 reference

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects

21 January 2018

1 reference

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers

21 January 2018

1 reference

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

21 January 2018

1 reference

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

21 January 2018

1 reference

Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis

21 January 2018

1 reference

Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria

21 January 2018

1 reference

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

21 January 2018

1 reference

The clinical efficacy of artemether/lumefantrine (Coartem)

21 January 2018

1 reference

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial

21 January 2018

1 reference

Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan

21 January 2018

1 reference

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

21 January 2018

1 reference

Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.

21 January 2018

1 reference

Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial

21 January 2018

1 reference

Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi

21 January 2018

1 reference

Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa

21 January 2018

1 reference

Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial

21 January 2018

1 reference

A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children

21 January 2018

1 reference

A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children

21 January 2018

1 reference

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance

21 January 2018

1 reference

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial

21 January 2018

1 reference

A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire

21 January 2018

1 reference

A trial of combination antimalarial therapies in children from Papua New Guinea.

21 January 2018

1 reference

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India

21 January 2018

1 reference

Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan

21 January 2018

1 reference

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

21 January 2018

1 reference

Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

21 January 2018

1 reference

Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

21 January 2018

1 reference

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia

21 January 2018

1 reference

Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire

21 January 2018

1 reference

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

21 January 2018

1 reference

Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission

21 January 2018

1 reference

The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence

21 January 2018

1 reference

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

21 January 2018

1 reference

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

21 January 2018

1 reference

Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

Safety profile of Coartem: the evidence base

21 January 2018

1 reference

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

21 January 2018

1 reference

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children

21 January 2018

1 reference

21 January 2018

1 reference

The safety of artemisinins during pregnancy: a pressing question

21 January 2018

1 reference

Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sufadoxine-pyrimethamine-resistant falciparum malaria during pregnancy

21 January 2018

1 reference

Artemether in the treatment of falciparum malaria during pregnancy in eastern Sudan

21 January 2018

1 reference

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

21 January 2018

1 reference

Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women

21 January 2018

1 reference

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

21 January 2018

1 reference

Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial

21 January 2018

1 reference

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

21 January 2018

1 reference

Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand

21 January 2018

1 reference

The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria

21 January 2018

1 reference

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

21 January 2018

1 reference

Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis

21 January 2018

1 reference

Malaria in infants below six months of age: retrospective surveillance of hospital admission records in Blantyre, Malawi

21 January 2018

1 reference

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa

21 January 2018

1 reference

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study

21 January 2018

1 reference

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia

21 January 2018

1 reference

Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area

21 January 2018

1 reference

The threat of artemisinin-resistant malaria

21 January 2018

1 reference

Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial

21 January 2018

1 reference

Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania

21 January 2018

1 reference

Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania

21 January 2018

1 reference

Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi

21 January 2018

1 reference

SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology

21 January 2018

1 reference

Shrinking the malaria map: progress and prospects

21 January 2018

1 reference

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance

21 January 2018

1 reference

Pitfalls in estimating piperaquine elimination

21 January 2018

1 reference

A research agenda for malaria eradication: drugs

21 January 2018

1 reference

Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

21 January 2018

1 reference

Imidazolopiperazines: hit to lead optimization of new antimalarial agents.

21 January 2018

1 reference

A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings

21 January 2018

1 reference

Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants

21 January 2018

1 reference

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

21 January 2018

1 reference

High prevalence of asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study

21 January 2018

1 reference

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

21 January 2018

1 reference

Improving malaria control in West Africa: interruption of transmission as a paradigm shift

21 January 2018

1 reference

Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.

21 January 2018

1 reference

Mass administrations of antimalarial drugs

21 January 2018

1 reference

The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia

21 January 2018

1 reference

Malaria eradication on islands

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.12.51

1 reference

8 September 2017

1 reference